Roundtable Discussion: Is Actinium-225 Ready for Mainstream Clinical Adoption? Balancing Scientific Promise with Development Reality

Name: Roundtable Discussion: Is Actinium-225 Ready for Mainstream Clinical Adoption? Balancing Scientific Promise with Development Reality
Start: 2026-12-02T11:45
Location: Renaissance London Heathrow Hotel

Targeted Radiopharmaceuticals Summit EU 2026 · 2 December 2026 · 11:45

Roundtable Discussion: Is Actinium-225 Ready for Mainstream Clinical Adoption? Balancing Scientific Promise with Development Reality was a session at Targeted Radiopharmaceuticals Summit EU 2026 on 2 December 2026 in London, with 1 speaker on record.

Speakers

Rich Edwards — Speaker Chief Technology Officer, Nuclide Therapeutics